Drug major Sun Pharma is recalling around 55,000 bottles ... unit of the Mumbai-based drug major is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, US Food and Drug Administration ...

Lupin, Sun Pharma recall Lisinopril and Clonazepam respectively in the US market The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to ...

Sun Pharma inks pact with Takeda to introduce gastrointestinal ... Dr Reddy's Laboratories Inc is recalling the affected lot of Sirolimus Tablets due to "Failed Impurities/Degradation ...

a vitamin and calcium tablet brand made by privately-owned Pure & Cure Healthcare, and several antibiotics, according to the lists for August. Pharmazz Inc. and Sun Pharma entered into an ...

Taro Pharmaceuticals Inc, a subsidiary of Sun Pharmaceutical Industries Ltd has entered into an agreement with Canada’s Antibe Therapeutics Inc, to acquire 100 per cent in the company.

Sun Pharmaceutical Industries Ltd is set to release its Q3 earnings for the quarter ending December 31, 2024, on Friday, January 31. The board will review and decide on the declaration of an ...

Drugmaker Sun Pharmaceutical Industries has entered into a definitive agreement to acquire 100% stake in Antibe Therapeutics Inc., an Ontario, Canada incorporated clinical-stage biotechnological ...

Sun Pharmaceutical Industries reported a 15 percent year-on-year rise in its consolidated net profit to Rs 2,903.4 crore for the third quarter of FY25, in line with Street estimates. The company's ...

Sun Pharma delivered a strong Q3 performance, surpassing Street expectations. However, concerns over the uncertain launch timeline of its hair loss drug Leqselvi and a cut in R&D spending have led ...